About Vitestro

Vitestro develops an autonomous blood drawing device that utilizes AI-based, ultrasound-guided imaging and robotic needle insertion to automate the entire blood collection process. This technology addresses the shortage of healthcare personnel by increasing the efficiency and availability of blood drawing services in hospitals, allowing patients to receive timely diagnostics on their own schedule.

```xml <problem> The increasing shortage of healthcare personnel strains the availability and efficiency of blood drawing services, a critical component of clinical diagnostics. This can lead to delays in diagnosis and treatment, impacting patient care and outcomes. </problem> <solution> Vitestro is developing an autonomous blood drawing device that automates the entire blood collection process, from tourniquet application to bandage placement. The device utilizes AI-based, ultrasound-guided imaging and robotic needle insertion to ensure accurate and secure blood collection. By automating the blood drawing workflow, Vitestro aims to increase the efficiency and availability of blood drawing services, reducing the workload on healthcare personnel and empowering patients to receive timely diagnostics on their own schedule. The device is designed to be intuitive and can be used under supervision by a wide range of patients. </solution> <features> - AI-based, ultrasound-guided imaging for vein localization - Robotic needle insertion for precise and automated blood collection - Fully automated procedure, including tourniquet and bandage application - Standardized blood drawing process to ensure consistent quality - Continuous operation to boost the availability of blood drawing services - Designed for a high level of patient safety and reduced anxiety - CE Marking, acknowledging the device meets the requirements of the European Medical Device Regulation (MDR) </features> <target_audience> The primary target audience includes hospitals, clinical laboratories, and healthcare providers seeking to improve the efficiency and availability of blood drawing services while addressing staffing shortages. </target_audience> ```

What does Vitestro do?

Where is Vitestro located?

Vitestro is based in Utrecht, The Netherlands.

When was Vitestro founded?

Vitestro was founded in 2017.

How much funding has Vitestro raised?

Vitestro has raised 34450000.

Location

Utrecht, The Netherlands

Founded

2017

Funding

34450000

Employees

114 employees

Major Investors

NYBC Ventures, Sonder Capital

Find Investable Startups and Competitors

Search thousands of startups using natural language

AI voice (2021+)underground pipe robots energy flexibility software

Start Searching

Vitestro

⚠️ AI-generated overview based on web search data – may contain errors, please verify information yourself! You can claim this account with your email domain to make edits.

Executive Summary

vitestro.com 5K+

Crunchbase

Founded 2017 – Utrecht, The Netherlands

Funding

Estimated Funding

$20M+

Major Investors

NYBC Ventures, Sonder Capital

Team (100+)

No team information available.

Company Description

Problem

The increasing shortage of healthcare personnel strains the availability and efficiency of blood drawing services, a critical component of clinical diagnostics. This can lead to delays in diagnosis and treatment, impacting patient care and outcomes.

Solution

Vitestro is developing an autonomous blood drawing device that automates the entire blood collection process, from tourniquet application to bandage placement. The device utilizes AI-based, ultrasound-guided imaging and robotic needle insertion to ensure accurate and secure blood collection. By automating the blood drawing workflow, Vitestro aims to increase the efficiency and availability of blood drawing services, reducing the workload on healthcare personnel and empowering patients to receive timely diagnostics on their own schedule. The device is designed to be intuitive and can be used under supervision by a wide range of patients.

Features

AI-based, ultrasound-guided imaging for vein localization

Robotic needle insertion for precise and automated blood collection

Fully automated procedure, including tourniquet and bandage application

Standardized blood drawing process to ensure consistent quality

Continuous operation to boost the availability of blood drawing services

Designed for a high level of patient safety and reduced anxiety

CE Marking, acknowledging the device meets the requirements of the European Medical Device Regulation (MDR)

Target Audience

The primary target audience includes hospitals, clinical laboratories, and healthcare providers seeking to improve the efficiency and availability of blood drawing services while addressing staffing shortages.